Anti‑inflammatory effect of
Animals
Anti-Inflammatory Agents
/ pharmacology
Cell Survival
/ drug effects
Chrysanthemum
/ chemistry
Cyclooxygenase 2
/ metabolism
Cytokines
/ metabolism
Dinoprostone
/ metabolism
Free Radical Scavengers
/ pharmacology
Glycyrrhiza
/ chemistry
Heme Oxygenase-1
/ metabolism
Inflammation
/ chemically induced
Lipopolysaccharides
/ toxicity
Macrophages
/ cytology
Membrane Proteins
/ metabolism
Mentha piperita
/ chemistry
Mice
NF-kappa B
/ antagonists & inhibitors
Nitric Oxide
/ metabolism
Nitric Oxide Synthase Type II
/ metabolism
Plant Extracts
/ pharmacology
Proto-Oncogene Proteins c-akt
/ antagonists & inhibitors
RAW 264.7 Cells
STAT1 Transcription Factor
/ metabolism
Signal Transduction
/ drug effects
Chrysanthemum zawadskii
Glycyrrhiza glabra
NF‑κB
STAT1
anti‑inflammation
herbal mixture
peppermint
Journal
Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
04
01
2021
accepted:
19
04
2021
entrez:
26
5
2021
pubmed:
27
5
2021
medline:
16
10
2021
Statut:
ppublish
Résumé
The normal inflammatory reaction protects the body from harmful external factors, whereas abnormal chronic inflammation can cause various diseases, including cancer. The purpose of the present study was to investigate the anti‑inflammatory activity of a mixture of
Identifiants
pubmed: 34036392
doi: 10.3892/mmr.2021.12171
pii: 532
pmc: PMC8170225
doi:
pii:
Substances chimiques
Anti-Inflammatory Agents
0
Cytokines
0
Free Radical Scavengers
0
Lipopolysaccharides
0
Membrane Proteins
0
NF-kappa B
0
Plant Extracts
0
STAT1 Transcription Factor
0
Stat1 protein, mouse
0
Nitric Oxide
31C4KY9ESH
Nitric Oxide Synthase Type II
EC 1.14.13.39
Nos2 protein, mouse
EC 1.14.13.39
Heme Oxygenase-1
EC 1.14.14.18
Hmox1 protein, mouse
EC 1.14.14.18
Cyclooxygenase 2
EC 1.14.99.1
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Dinoprostone
K7Q1JQR04M
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
FASEB J. 1992 Sep;6(12):3051-64
pubmed: 1381691
J Toxicol Sci. 2013;38(6):875-8
pubmed: 24213006
Medicines (Basel). 2019 May 10;6(2):
pubmed: 31083310
Biochim Biophys Acta. 2006 Jan;1765(1):74-84
pubmed: 16169156
Allergy. 2001 Dec;56(12):1164-71
pubmed: 11736745
Int Immunopharmacol. 2016 Jul;36:282-290
pubmed: 27208432
Eur J Pharmacol. 2017 Apr 15;801:46-53
pubmed: 28263754
Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):39-58
pubmed: 29336271
BMC Complement Altern Med. 2017 Jul 28;17(1):374
pubmed: 28754101
Inflamm Res. 2015 Aug;64(8):577-88
pubmed: 26059394
Inflammation. 2014 Jun;37(3):756-65
pubmed: 24385238
J Immunotoxicol. 2016 Jul;13(4):509-25
pubmed: 27438966
Sci Rep. 2017 Sep 14;7(1):11551
pubmed: 28912423
Int Immunopharmacol. 2016 Nov;40:146-155
pubmed: 27591413
Molecules. 2018 Jul 27;23(8):
pubmed: 30060484
Trends Mol Med. 2007 Nov;13(11):460-9
pubmed: 18029230
BMC Complement Altern Med. 2015 Dec 23;15:447
pubmed: 26698114
Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):950-8
pubmed: 27010156
J Biomed Sci. 2011 May 06;18:28
pubmed: 21548916
BMC Complement Altern Med. 2019 Oct 21;19(1):274
pubmed: 31638961
Science. 2001 Nov 30;294(5548):1871-5
pubmed: 11729303
Chem Biol Interact. 2018 Mar 1;283:97-106
pubmed: 29427589
Cytotechnology. 2017 Dec;69(6):915-924
pubmed: 28608258
Molecules. 2018 Mar 06;23(3):
pubmed: 29509670
Phytother Res. 2006 Aug;20(8):619-33
pubmed: 16767798
Dig Dis Sci. 2007 Aug;52(8):1890-6
pubmed: 17404846
Biochem J. 1996 May 15;316 ( Pt 1):209-15
pubmed: 8645207
Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12013-7
pubmed: 7991575
Appl Microbiol Biotechnol. 2016 Feb;100(4):1645-1666
pubmed: 26711278
Int Immunopharmacol. 2014 Jul;21(1):171-80
pubmed: 24825603
Bioorg Med Chem Lett. 2016 Oct 1;26(19):4592-4598
pubmed: 27590705
J Environ Pathol Toxicol Oncol. 2002;21(2):93-101
pubmed: 12086407
Molecules. 2016 Mar 28;21(4):422
pubmed: 27043497